OncoMed Pharmaceuticals, Inc. , a clinical-stage company developing novel therapeutics that target cancer stem cells , or tumor-initiating cells, today announced the appointment of independent director Michael Wyzga to the company's Board of Directors.
http://www.drugs.com/news/oncomed-pharmaceuticals-appoints-michael-wyzga-board-directors-48309.html?
http://www.drugs.com/news/oncomed-pharmaceuticals-appoints-michael-wyzga-board-directors-48309.html?
No comments:
Post a Comment